Literature DB >> 7950389

Overexpression and purification of the vaccinia virus DNA polymerase.

W F McDonald1, P Traktman.   

Abstract

We have overexpressed the vaccinia virus DNA polymerase using the hybrid vaccinia virus/T7 expression system. Accumulation of the DNA polymerase to levels as high as 10% of the total protein was observed following coinfection of BSC40 cells with the appropriate vaccinia recombinants. Although the DNA polymerase produced at 37 degrees C was largely insoluble, 25% of the recombinant protein could be recovered as soluble protein when infected cultures were maintained at 32 degrees C. Starting with cytoplasmic lysates of coinfected cells, a rapid and reproducible purification protocol that yielded apparently homogeneous preparations of the DNA polymerase after four chromatographic steps was established. Typically, 0.3 mg of purified DNA polymerase was obtained from 27 mg of total protein within 10 h after harvesting infected cells. As was previously described for the DNA polymerase purified from vaccinia-infected cells (Challberg and Englund, J. Biol. Chem., 254, 7812-7819, 1979), the purified recombinant enzyme displayed both polymerase and 3'-5' exonuclease activities but lacked detectable 5'-3' exonuclease activity. Kinetic analysis of nucleotide incorporation catalyzed by the vaccinia enzyme revealed apparent Km values of 0.9, 2.9, 4.0, and 2.7 microM for dGTP, dATP, TTP, and dCTP, respectively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7950389     DOI: 10.1006/prep.1994.1059

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  21 in total

1.  The A20R protein is a stoichiometric component of the processive form of vaccinia virus DNA polymerase.

Authors:  N Klemperer; W McDonald; K Boyle; B Unger; P Traktman
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Clustered charge-to-alanine mutagenesis of the vaccinia virus A20 gene: temperature-sensitive mutants have a DNA-minus phenotype and are defective in the production of processive DNA polymerase activity.

Authors:  A Punjabi; K Boyle; J DeMasi; O Grubisha; B Unger; M Khanna; P Traktman
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Effects of DNA structure and homology length on vaccinia virus recombination.

Authors:  X D Yao; D H Evans
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Cell biological and functional characterization of the vaccinia virus F10 kinase: implications for the mechanism of virion morphogenesis.

Authors:  Almira Punjabi; Paula Traktman
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Enzymatic processing of replication and recombination intermediates by the vaccinia virus DNA polymerase.

Authors:  Michael D Hamilton; David H Evans
Journal:  Nucleic Acids Res       Date:  2005-04-20       Impact factor: 16.971

Review 6.  The vaccinia virus DNA polymerase and its processivity factor.

Authors:  Maciej W Czarnecki; Paula Traktman
Journal:  Virus Res       Date:  2017-02-01       Impact factor: 3.303

7.  Characterization of the single-stranded DNA binding protein encoded by the vaccinia virus I3 gene.

Authors:  S C Rochester; P Traktman
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  Evaluation of the role of the vaccinia virus uracil DNA glycosylase and A20 proteins as intrinsic components of the DNA polymerase holoenzyme.

Authors:  Kathleen A Boyle; Eleni S Stanitsa; Matthew D Greseth; Jill K Lindgren; Paula Traktman
Journal:  J Biol Chem       Date:  2011-05-13       Impact factor: 5.157

9.  Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate.

Authors:  Wendy C Magee; Karl Y Hostetler; David H Evans
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 10.  Mechanistic cross-talk between DNA/RNA polymerase enzyme kinetics and nucleotide substrate availability in cells: Implications for polymerase inhibitor discovery.

Authors:  Si'Ana A Coggins; Bijan Mahboubi; Raymond F Schinazi; Baek Kim
Journal:  J Biol Chem       Date:  2020-07-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.